InvestorsHub Logo

29YEARINVESTOR

05/23/22 1:12 PM

#108613 RE: HighYieldStocks #108610

4 Cancer Treatment related Patents Granted in the past 10 months.
Fast track!
Pay the $50 and know what others now know!
https://adisinsight.springer.com/drugs/800045610
10 Mar 2022 NR2F6 receptor modulators are still in preclinical development stage for Cancer and Autoimmune disorders in USA
New Molecular Entity Yes
Available For Licensing Yes